MedVi vs LTTL: Compare prices, compounded GLP-1 options
MedVi vs LTTL: quick verdict — MedVi is a clear choice if you want a low promotional first month, a fully online intake, and 24/7 certified medical support. Lttl stands out if you prioritize verified pharmacy compounding, consistent dose verification, and an advertised first-month credit up to $140.
Start MedVi at $179 first month
How MedVi and Lttl differ: price, medication type, and verification
This comparison focuses on the most distinctive supported differences between MedVi and Lttl: promotional pricing structure, medication type and compounding, clinician review and support model, and pharmacy verification and dose confirmation.
Price and promotional offers
MedVi advertises a winter promotional first month starting at $179 including fast, free shipping, but notes a higher ongoing standalone month price ($299) and a three-month plan at $649. Lttl advertises up to $140 off your first month with a code auto-applied and lists pricing cues such as $249 and $129 in captured evidence. Both operate as direct-pay for compounded medications; specific ongoing pricing details for Lttl beyond the first-month credit were not published on the captured landing page.
Medication type and regulatory notes
MedVi provides clinically dosed compounded semaglutide and emphasizes semaglutide only, with explicit regulatory language that compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality. Lttl offers compounded GLP-1 medications and includes the same regulatory note that compounded medications are not FDA-approved. Each provider makes claims about compounding; MedVi also contrasts compounded options with branded products but does not claim FDA approval for its compounded drugs.
Clinician review, support, and eligibility
MedVi describes a fully online intake with no clinic visits needed and 24/7 support from certified medical professionals; OpenLoop Health clinicians review cases after checkout and retain prescribing discretion. Lttl states treatment is available only when a licensed clinician determines it is medically appropriate and advises confirming eligibility, medication, total cost, renewal terms, and state availability before enrollment. Both require clinician review and both emphasize that prescriptions are subject to clinical determination.
Pharmacy standards and dose verification
MedVi says its compounded GLP-1s are produced in FDA-regulated facilities and that it partners with multiple USA certified pharmacies, while noting compounded medications are not FDA-approved. Lttl states its medications are compounded by U.S.A. licensed pharmacies, independently verified in FDA registered labs, and confirmed every 3 to 6 months to stay within plus or minus 10 percent of the target strength. The captured evidence for Lttl emphasizes independent verification and regular confirmation of target strength.
Comparison table: MedVi vs Lttl
| Criteria | MedVi | Lttl |
|---|---|---|
| Promotional first month | Starting at $179 with fast, free shipping | Up to $140 off first month, code auto-applied |
| Ongoing price notes | Standalone month $299; three-month plan $649 | Captured details not fully published; listed prices include $249 and $129 cues |
| Medication type | Compounded semaglutide only | Compounded GLP-1 medications (full-dose) |
| Clinician review and support | Online intake, no clinic visits, 24/7 certified medical support; clinician discretion applies | Treatment only when a licensed clinician deems appropriate; eligibility and terms advised to confirm |
| Pharmacy verification | Partners with USA certified pharmacies; medications produced in FDA-regulated facilities, not FDA-approved | Compounded by U.S.A. licensed pharmacies; independently verified in FDA registered labs; dose confirmation every 3-6 months |
Practice and outcome claims included in source
MedVi references patient-reported data such as average weight loss and program adherence context, while noting results vary and are not guaranteed. Lttl copy emphasizes appetite regulation and lasting weight loss in captured lines but does not publish expanded outcome evidence on the captured landing page. Both reiterate that compounded medications are not FDA-approved.
Which to choose: MedVi vs LTTL
Choose MedVi if you want a low promotional entry price starting at $179, a simple online intake with no clinic visits, and 24/7 certified medical support. Choose Lttl if you want compounded GLP-1s that the captured evidence says are independently verified in FDA registered labs with regular dose confirmation and an advertised first-month credit up to $140.
MedVi vs LTTL: both offer compounded GLP-1 treatment paths with clinician review and regulatory disclaimers that compounded medications are not FDA-approved. Confirm eligibility, pricing, renewal terms, and state availability with each provider before enrolling.